IRIS
BALLESTRERO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 29.309
AS - Asia 3.269
NA - Nord America 2.180
SA - Sud America 286
AF - Africa 65
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 35.121
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 28.717
US - Stati Uniti d'America 2.026
SG - Singapore 1.345
CN - Cina 811
VN - Vietnam 583
FR - Francia 228
BD - Bangladesh 188
BR - Brasile 170
HK - Hong Kong 111
DE - Germania 89
CA - Canada 80
FI - Finlandia 75
AR - Argentina 64
GB - Regno Unito 47
JP - Giappone 44
IN - India 41
MX - Messico 37
IQ - Iraq 30
ID - Indonesia 26
NL - Olanda 22
CH - Svizzera 19
ZA - Sudafrica 17
EC - Ecuador 16
ES - Italia 16
IE - Irlanda 14
PH - Filippine 13
RU - Federazione Russa 13
MA - Marocco 12
UA - Ucraina 11
UZ - Uzbekistan 11
CL - Cile 10
AU - Australia 9
PK - Pakistan 9
SE - Svezia 9
TH - Thailandia 9
TR - Turchia 9
VE - Venezuela 9
KE - Kenya 7
LT - Lituania 7
AT - Austria 6
JM - Giamaica 6
PL - Polonia 6
PY - Paraguay 6
DZ - Algeria 5
KR - Corea 5
PA - Panama 5
AL - Albania 4
CO - Colombia 4
EG - Egitto 4
GR - Grecia 4
HN - Honduras 4
NP - Nepal 4
SV - El Salvador 4
TN - Tunisia 4
UY - Uruguay 4
ET - Etiopia 3
GT - Guatemala 3
JO - Giordania 3
RO - Romania 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
AZ - Azerbaigian 2
BB - Barbados 2
BE - Belgio 2
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
DK - Danimarca 2
GH - Ghana 2
IL - Israele 2
KZ - Kazakistan 2
MM - Myanmar 2
MT - Malta 2
PE - Perù 2
PR - Porto Rico 2
PT - Portogallo 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LB - Libano 1
Totale 35.105
Salva come PNG Salva come JPEG
Città #
Genova 15.298
Genoa 8.386
Rapallo 2.675
Vado Ligure 1.873
Singapore 641
San Jose 589
Ashburn 288
Lauterbourg 207
Ho Chi Minh City 186
Beijing 132
Hanoi 117
Council Bluffs 115
New York 115
Milan 112
Hong Kong 107
Helsinki 68
Frankfurt am Main 65
Los Angeles 60
Bordighera 55
Santa Clara 53
Tokyo 39
Valenza 35
Montreal 32
Dallas 26
Da Nang 25
Rome 25
São Paulo 24
Haiphong 23
Orem 22
Buffalo 21
Mexico City 21
Atlanta 20
Chicago 16
Biên Hòa 15
Boardman 15
Turin 15
Johannesburg 14
Tianjin 14
Zurich 14
City of London 13
London 13
Amsterdam 12
Dublin 12
Memphis 12
Toronto 12
Can Tho 11
Des Moines 11
Nuremberg 11
Rovereto 11
Naples 10
Phoenix 10
Baghdad 9
Charlotte 9
Delhi 9
Paris 9
Piscataway 9
Buenos Aires 8
Houston 8
Quảng Ngãi 8
Stockholm 8
Ancona 7
Brooklyn 7
Cardiff 7
Madrid 7
Marseille 7
Sydney 7
Tashkent 7
Xi'an 7
Dhaka 6
Hải Dương 6
Lappeenranta 6
Long Xuyen 6
Modena 6
Mumbai 6
Rio de Janeiro 6
San Francisco 6
Thái Nguyên 6
Bologna 5
Boston 5
Casablanca 5
Chennai 5
Denver 5
La Spezia 5
Miami 5
Nairobi 5
Nha Trang 5
Panama City 5
Phủ Lý 5
Santiago 5
Shenzhen 5
Vĩnh Long 5
Vĩnh Tường 5
Warsaw 5
Acalanes Ridge 4
Bắc Ninh 4
Columbus 4
Florence 4
Fortaleza 4
Guangzhou 4
Guayaquil 4
Totale 31.991
Salva come PNG Salva come JPEG
Nome #
A modular framework for the development of targeted Covid-19 blood transcript profiling panels 340
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 317
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 304
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. 280
Advances in dynamic modeling of colorectal cancer signaling-network regions, a path toward targeted therapies. 273
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 264
HMGA2 overexpression in plycythemia vera with t(12;21) (q14;q22) 256
1222 POSTER Chemical Screening for Potentiators of Lapatinib Activity in Human Breast Cancer 254
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 252
Grb7 upregulation is a molecular adaptation to HER2 signaling inhibition due to removal of AKT-mediated gene repression 249
APO866 activity in hematologic malignancies: a preclinical in vitro study. 247
1221 POSTER Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 245
P-334 * Radiological assessments for select patients in neoadjuvant setting in rectal cancer: monoinstitutional experience 245
Nicotinic acid phosphoribosyltransferase regulates cancer cell metabolism, susceptibility to NAMPT inhibitors and DNA repair. 236
Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation 235
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 231
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics 226
DNA aneuploidy relationship with patient age and tobacco smoke in OPMDs/OSCCs 221
Catastrophic NAD(+) Depletion in Activated T Lymphocytes through Nampt Inhibition Reduces Demyelination and Disability in EAE 219
Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial 214
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia 213
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 213
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 210
Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancer 207
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 206
Uncovering the genomic heterogeneity of multifocal breast cancer 205
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity. 204
Proteasome inhibitors as immunosuppressants: biological rationale and clinical experience. 203
A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation 203
Abstract 49: Agreement of immunohistochemistry, fluorescence in situ hybridization, real-time quantitative polymerase-chain reaction, and quantitative reverse transcriptase PCR for Her-2/Neu status assessment in breast cancer patients: a single center, retrospective m 202
Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. 202
Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study 201
Ras-induced resistance to lapatinib is overcome by MEK inhibition 200
Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. 199
Discovery of novel and selective SIRT6 inhibitors. 199
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. 198
Sirt6 regulates dendritic cell differentiation, maturation, and function 196
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 195
Dynamic Simulations of Pathway Cross-talks Relevant in Colorectal Cancer: A Quantitative Parameter Sensitivity Analysis 194
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 193
Parameter Space Exploration within Dynamic Simulations of Signaling Networks 193
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. 192
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 192
ANTITUMOR ACTIVITY OF NAMPT INHIBITION AND SYNERGY WITH CYCLOSPORIN A AND HDACIS TO PROMOTE APOPTOSIS IN PRIMARY LEUKEMIC CELLS 192
Fasting potentiates the anticancer activity of tyrosin kinase inhibitors by strenghtening MAPK signalling inhibition. 191
Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes. possible relevance to the assays for the detection of micrometastatic breast cancer 190
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 189
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 188
Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis. 188
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells. 188
Squalene epoxidase as a promising metabolic target in cancer treatment 187
Pegfilgrastim compared with filgrastim after autologous peripheral blood stem cell transplantation in patients with solid tumours and lymphomas. 187
Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer 187
Patient-tailored treatments with anti-EGFR monoclonal antibodies in advanced colorectal cancer: KRAS and beyond. 185
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments. Concordance with experimental results. 183
Circulating tumor DNA using tagged targeted deep sequencing to assess minimal residual disease in breast cancer patients undergoing neoadjuvant chemotherapy 183
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 183
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry. 182
EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition 182
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. 181
Schlafen 11 Assessment in High-Grade Serous Ovarian Carcinoma: Phenotypic and Histological Distribution 181
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 180
Dynamic simulations of pathways downstream of TGF-beta , Wnt and EGF-family growth factors, in colorectal cancer, including mutations and treatments with onco-protein inhibitors 178
Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases 178
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. 177
Hedgehog Signaling Is Useful as a Novel Molecular Marker for Predicting Relapse and Resistance During Chronic Myeloid Leukemia Treatment 177
Clinical predictors of late SARS-CoV-2 positivity in Italian internal medicine wards 177
Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols. 176
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 176
Chemical-genetic Screenings for Synthetic-lethal Interactions in Breast Cancer 175
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 174
Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells. 174
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cells 173
Systems medicine in oncology: Signaling network modeling and new-generation decision-support systems 173
Three-step high-dose sequential chemotherapy in patients with newly diagnosed multiple myeloma 172
Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer 172
Frailty assessment in elective gastrointestinal oncogeriatric surgery: Predictors of one-year mortality and functional status 170
Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study 169
High-dose cyclophosphamide followed by gm-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells 169
Dendritic cells transfected with tumor RNA for the induction of antitumor CTL in colorectal cancer 169
Activation of the death receptor apoptosis pathway by TRAIL overcomes anticancer drug resisitance in antiapoptotic bcl-2 family members expressing lymphoma cells 168
Quantitative Real Time PCR assessment of hormonal receptors and HER2 status on fine-needle aspiration pre-operatory specimens from a prospectively accrued cohort of women with suspect breast malignant lesions. 168
Molecular characterization of an Italian series of sporadic GISTs. 167
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 166
The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer. 166
Nicotinamide Phosphoribosyltransferase As A Target In Inflammation-Related Disorders. 166
Report on the first SLFN11 monothematic workshop: from function to role as a biomarker in cancer 165
The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level 164
Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol 164
Diagnosis of lung cancer following emergency admission: Examining care pathways, clinical outcomes, and advanced NSCLC treatment in an Italian cancer Center 162
Proteasome inhibitor-induced apoptosis in human monocyte-derived dendritic cells. 162
Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells 162
Improvement in Waldenstrom’s macroglobulinemia after successful treatment of HCV with direct-acting antivirals 162
Dual NAMPT and BTK targeting leads to synergistic killing of Waldenström macroglobulinemia cells regardless of MYD88 and CXCR4 somatic mutation status 162
Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8 162
Tracking molecular relapse of chronic myeloid leukemia by measuring Hedgehog signaling status 160
The use of dendritic cells in cancer immunotherapy. 160
Immunotherapy with dendritic cells for cancer 159
Reduced intensity conditioning for allograft after cytoreductive autograft in metastatic breast cancer 158
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents 158
Totale 19.645
Salva come PNG Salva come JPEG
Categoria #
all - tutte 109.234
article - articoli 105.558
book - libri 0
conference - conferenze 2.340
curatela - curatele 0
other - altro 0
patent - brevetti 325
selected - selezionate 0
volume - volumi 1.011
Totale 218.468
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021146 0 0 0 0 0 0 0 0 0 0 0 146
2021/20222.717 94 185 154 366 142 212 180 538 153 239 139 315
2022/20233.224 289 297 23 360 558 484 31 237 479 18 392 56
2023/20241.835 71 213 39 245 150 314 102 156 88 48 111 298
2024/20255.409 204 314 164 402 549 493 489 1.019 200 228 536 811
2025/20269.470 1.174 305 629 759 1.265 759 1.407 457 715 1.053 707 240
Totale 35.647